Evaxion A (EVAX) Change in Intangibles (2020 - 2021)

Evaxion A (EVAX) posted Change in Intangibles of -$60000.0 for Q3 2021, little changed on a QoQ basis from -$60000.0 in Q2 2021, and down 71.43% year-over-year from -$210000.0 in Q3 2020.

Evaxion A (EVAX) Change in Intangibles (2020 - 2021) Analysis & Trends

Evaxion A's Change in Intangibles history runs 2 years deep, the most recent figure standing at -$60000.0 for Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn - -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn - -
3 Akari Therapeutics 1,021.31 Bn 1,021.31 Bn - -
4 BeOne Medicines 467.89 Bn 463.10 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.19 Bn 61.44 Bn 3.31 Bn -
7 Belite Bio 63.46 Bn 63.46 Bn - -
8 Argenx Se 55.64 Bn 50.45 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn -
10 Evaxion A 1.24 Bn 1.24 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 -60,000.00
Sep 30, 2021 -60,000.00
Jun 30, 2021 -60,000.00
Jun 30, 2021 -60,000.00
Mar 31, 2021 -60,000.00
Mar 31, 2021 -60,000.00
Sep 30, 2020 -35,000.00
Sep 30, 2020 -35,000.00
Jun 30, 2020 -35,000.00
Jun 30, 2020 -35,000.00